Cytokinetics Inc’s filing revealed that its President & CEO Blum Robert I unloaded Company’s shares for reported $1.18 million on Jun 17 ’24. In the deal valued at $52.60 per share,22,500 shares were sold. As a result of this transaction, Blum Robert I now holds 416,645 shares worth roughly $22.46 million.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Then, PARSHALL B LYNNE sold 5,000 shares, generating $262,750 in total proceeds. Upon selling the shares at $52.55, the Director now owns 20,600 shares.
Before that, Malik Fady Ibraham sold 7,788 shares. Cytokinetics Inc shares valued at $413,106 were divested by the EVP Research & Development at a price of $53.04 per share. As a result of the transaction, Malik Fady Ibraham now holds 135,004 shares, worth roughly $7.28 million.
UBS downgraded its Cytokinetics Inc [CYTK] rating to a Neutral from a a Buy in a research note published on January 24, 2024; the price target was increased to $92 from $61. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who decreased its forecast for the stock in early January from “an Overweight” to “an Equal-weight”. Goldman began covering CYTK with “Buy” recommendation on November 09, 2023. B. Riley Securities started covering the stock on November 07, 2023. It rated CYTK as “a Buy”.
Price Performance Review of CYTK
On Monday, Cytokinetics Inc [NASDAQ:CYTK] saw its stock jump 0.71% to $53.90. Over the last five days, the stock has lost -0.06%. Cytokinetics Inc shares have fallen nearly -35.44% since the year began. Nevertheless, the stocks have risen 44.81% over the past one year. While a 52-week high of $110.25 was reached on 01/08/24, a 52-week low of $25.98 was recorded on 05/28/24. SMA at 50 days reached $58.73, while 200 days put it at $55.73. A total of 1.08 million shares were traded, compared to the trading of 1.08 million shares in the previous session.
Levels Of Support And Resistance For CYTK Stock
The 24-hour chart illustrates a support level at 53.08, which if violated will result in even more drops to 52.27. On the upside, there is a resistance level at 54.64. A further resistance level may holdings at 55.39. The Relative Strength Index (RSI) on the 14-day chart is 48.13, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.21, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 13.78%. Stochastics %K at 75.94% indicates the stock is a holding.
#####
#####
#####
The most recent change occurred on August 15, 2023 when SVB Securities began covering the stock and recommended ‘”an Outperform”‘ rating along with a $58 price target.
